GleamWall
中文EN

CAH CARDINAL HEALTH INC

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 721371 · Fiscal year ends 06/30

Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY14.2%
TTM net income YoY9.8%
TTM EPS YoY12.1%
Revenue 3-yr CAGR7.4%
Net income 3-yr CAGR73.2%

Margins

Gross margin3.8%
Operating margin1.0%
Net margin0.7%
FCF margin1.8%
EBITDA margin1.4%

Returns

ROE—
ROA3.1%
ROIC (approx.)135.8%
Asset turnover4.61x

Leverage & solvency

Liabilities / assets104.8%
Debt / equity—
Current ratio0.88x
Interest coverage7.51x

Cash quality & payout

Operating cash flow / net income3.02x
Accruals ratio-6.3%
Payout ratio28.6%
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-312025Q12024-09-302024Q4*2024-06-30
Income statement
Revenue$67.51B$65.63B$64.01B$60.16B$54.88B$55.26B$52.28B$59.71B
Cost of revenue$64.92B$63.23B$61.69B$57.96B$52.76B$53.32B$50.38B$57.85B
Gross profit$2.60B$2.40B$2.32B$2.20B$2.12B$1.94B$1.90B$1.85B
SG&A expense$1.59B$1.50B$1.46B$1.48B$1.31B$1.31B$1.28B$1.24B
Operating income$753.00M$707.00M$668.00M$428.00M$730.00M$549.00M$568.00M$408.00M
Interest expense$73.00M$88.00M$80.00M$74.00M$74.00M$35.00M$32.00M-$4.00M
Pretax income$688.00M$630.00M$598.00M$384.00M$665.00M$511.00M$541.00M$391.00M
Income tax$132.00M$159.00M$144.00M$141.00M$157.00M$110.00M$124.00M$162.00M
Net income$554.00M$467.00M$450.00M$239.00M$506.00M$400.00M$416.00M$236.00M
EBITDA$1.00B$941.00M$901.00M$637.00M$937.00M$741.00M$750.00M$594.00M
EPS (basic)2.39—1.89———1.71—
EPS (diluted)2.38—1.88———1.70—
Dividends declared per share0.520.510.510.500.510.510.510.50
Weighted avg. shares (diluted)233.00M237.00M239.00M—241.00M243.00M245.00M—
Balance sheet
Cash & equivalents$5.26B$2.78B$4.59B$3.87B$3.33B$3.81B$2.87B$5.13B
Short-term investments———————$200.00M
Receivables$14.54B$13.66B$13.77B$13.24B$12.67B$12.37B$11.78B$12.08B
Inventory$18.39B$20.12B$17.56B$16.83B$16.16B$16.90B$15.62B$14.96B
Current assets$40.99B$39.23B$38.54B$36.37B$34.59B$35.76B$32.91B$34.88B
PP&E, net$3.00B$2.88B$2.83B$2.86B$2.66B$2.56B$2.54B$2.53B
Goodwill$11.54B$11.61B$9.71B$9.69B$8.91B$5.49B$4.72B$4.72B
Intangibles$2.15B$2.37B$2.40B$2.49B$2.11B$1.95B$1.66B$1.73B
Total assets$59.54B$58.08B$55.23B$53.12B$49.87B$47.00B$43.06B$45.12B
Current liabilities$46.33B$43.31B$40.27B$38.90B$36.66B$35.22B$34.68B$35.64B
Short-term debt$1.89B$680.00M$52.00M$550.00M$543.00M$544.00M$940.00M$434.00M
Long-term debt$6.93B$8.35B$8.98B$7.98B$7.14B$7.06B$4.22B$4.66B
Total debt$8.81B$9.03B$9.03B$8.53B$7.68B$7.61B$5.16B$5.09B
Total liabilities$62.41B$60.78B$57.96B$55.76B$51.77B$49.92B$46.34B$48.33B
Shareholders' equity-$3.02B-$2.88B-$2.88B-$2.78B-$2.95B-$2.99B-$3.28B-$3.21B
Net debt$3.55B$6.25B$4.44B$4.65B$4.35B$3.80B$2.30B-$41.00M
Cash flow statement
Operating cash flow$1.40B$686.00M$973.00M$1.53B$2.92B-$400.00M-$1.65B$2.08B
Capital expenditure$157.00M$131.00M$108.00M$232.00M$126.00M$99.00M$90.00M$193.00M
Free cash flow$1.24B$555.00M$865.00M$1.29B$2.79B-$499.00M-$1.74B$1.88B
Investing cash flow-$251.00M-$1.98B-$142.00M-$1.63B-$2.90B-$976.00M-$88.00M$166.00M
Financing cash flow-$742.00M-$519.00M-$110.00M$656.00M-$507.00M$2.33B-$540.00M-$859.00M
Depreciation & amortization$247.00M$234.00M$233.00M$209.00M$207.00M$192.00M$182.00M$186.00M
Stock-based compensation$109.00M$31.00M$93.00M$153.00M$32.00M$30.00M$30.00M$33.00M
Dividends paid$126.00M$122.00M$129.00M$120.00M$124.00M$122.00M$128.00M$122.00M
Share buybacks$500.00M$383.00M$375.00M$0$375.00M$15.00M$375.00M$0

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.